The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Dr. Cathy Creticos with the Howard Brown Health Center has been at the forefront of HIV and AIDS research and treatment for ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

A population-based study finds that nearly 15% of individuals using HIV preexposure prophylaxis are diagnosed with alcohol ...

Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and increase access to a medication used to prevent HIV.